Wantai Biotech’s announcement on the completion of industrial and commercial change registration and renewal of business license for its wholly-owned subsidiary
Securities code: 603392 Securities abbreviation: Wantai Biotechnology Announcement number: 2026-004
Beijing Wantai Biopharmaceutical Co., Ltd.
Regarding the completion of industrial and commercial change registration for wholly-owned subsidiaries
Announcement on the renewal of business license
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Xiamen Wantai Carey Biotechnology Co., Ltd. (hereinafter referred to as "Wantai Carey"), a wholly-owned subsidiary of Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), has changed its business scope due to business development needs. At the same time, the address was changed from "2nd Floor, No. 124, Xinyuan Road, Xinyang Street, Haicang District, Xiamen City" to "1st Floor, No. 9-1 Hutou Road, Haicang District, Xiamen City".
Recently, Wantai Carey completed the industrial and commercial change registration procedures and obtained the "Business License" renewed by the Xiamen Haicang District Market Supervision and Administration Bureau. The relevant information is as follows:
Company Name: Xiamen Wantai Kairui Biotechnology Co., Ltd.
Unified social credit code: 91350205072826899U
Type: Legal person commercial entity [Limited liability company (sole proprietorship of a legal person invested or controlled by a natural person)] Address: 1st Floor, No. 9-1 Hutou Road, Haicang District, Xiamen City
Legal representative: Sun Xudong
Registered capital: 500 million yuan
Date of establishment: August 2, 2013
Business period: from August 2, 2013 to August 1, 2063
Business scope: Licensed projects: production of Class III medical devices; operation of Class III medical devices; leasing of Class III medical devices; production of Class II medical devices; pharmaceutical production; import and export of pharmaceuticals. (Projects that require approval according to law can only be carried out after approval by relevant departments. Specific business projects are subject to approval documents or licenses from relevant departments.) General projects: production of Class I medical devices; sales of Class I medical devices; sales of Class I medical devices; sales of Class II medical devices; leasing of Class II medical devices; sales of plastic products; manufacturing of special chemical products (excluding hazardous chemicals); housing leasing; engineering and technology research and experimental development; import and export of goods; technology import and export; technical services, technology development, technical consultation, technical exchanges, technology transfer, and technology promotion. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law) This is hereby announced.
Board of Directors of Beijing Wantai Biopharmaceutical Co., Ltd.
January 17, 2026